Daniel Meruelo, PhD
Principal Investigator
Daniel.Meruelo@nyulangone.orgDaniel.Meruelo@nyulangone.org
Daniel Meruelo is a Professor in the Department of Pathology and the Director of New York University School of Medicine’s Gene Therapy Center. His research led to the discovery of a new cancer treatment strategy that is currently undergoing preclinical and clinical testing. He received his Ph.D in biochemistry/Immunology from John Hopkins University in 1974, and was a Postdoctoral Fellow in Immunogenetics at Stanford University. Dr. Meruelo has received funding from Cynvec and the National Institutes of Health, the Department of Defense and other foundations to fund his research efforts on oncolytic Sindbis viral vectors.
Silvana Opp
Postdoctoral Fellow
Ph.D., University of Heidelberg
High-dimensional analysis and visualization of immune cells in vivo
Iris Scherwitzl, PhD
Postdoctoral Fellow
Iris.scherwitzl@nyulangone.org
PhD, Imperial College London
High-dimensional analysis and visualization of immune cells in vivo
Christine Pampeno
Research Scientist
Christine.Pampeno@nyulangone.org
PhD, City University of New York
Molecular biology and engineering of immuno-modulatory Sindbis virus vectors
Alicia Hurtado Martinez
Research Scientist
Alicia.HurtadoMartinez@nyulangone.org
PhD, Autonoma University of Madrid (Spain)
Generation of murine cancer models and in vivo study of Sindbis-Vectors therapy efficacy.
Ziyan Lin
Bioinformatics Analyst
Master, New York University
Analyzing High-Throughput sequencing data.